UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy

被引:82
作者
Diez, P. [1 ]
Hanna, G. G. [2 ,3 ]
Aitken, K. L. [4 ,5 ]
van As, N. [5 ,6 ]
Carver, A. [7 ]
Colaco, R. J. [8 ]
Conibear, J. [9 ]
Dunne, E. M. [10 ]
Eaton, D. J. [1 ,11 ,12 ]
Franks, K. N. [13 ]
Good, J. S. [14 ]
Harrow, S. [15 ]
Hatfield, P. [13 ]
Hawkins, M. A. [16 ,17 ]
Jain, S. [2 ,3 ]
McDonald, F. [5 ,6 ]
Patel, R. [1 ]
Rackley, T. [18 ]
Sanghera, P. [14 ]
Tree, A. [4 ,6 ]
Murray, L. [19 ]
机构
[1] Mt Vernon Canc Ctr, Natl Radiotherapy Trials Qual Assurance Grp RTTQA, Radiotherapy Phys, Northwood, Middx, England
[2] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland
[3] Queens Univ Belfast, Belfast, Antrim, North Ireland
[4] Royal Marsden NHS Fdn Trust, Dept Radiotherapy, Sutton, Surrey, England
[5] Inst Canc Res, London, England
[6] Royal Marsden NHS Fdn Trust, Dept Radiotherapy, London, England
[7] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Med Ctr, Dept Med Phys, Birmingham, W Midlands, England
[8] Christie Hosp NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England
[9] Barts Canc Ctr, Radiotherapy Dept, London, England
[10] Guys & St Thomas NHS Fdn Trust, Dept Clin Oncol, London, England
[11] Guys & St Thomas NHS Fdn Trust, Dept Med Phys, London, England
[12] Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England
[13] St James Univ Hosp, Dept Clin Oncol, Leeds Canc Ctr, Leeds, W Yorkshire, England
[14] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Dept Clin Oncol, Birmingham, W Midlands, England
[15] Western Gen Hosp, Edinburgh Canc Ctr, Dept Clin Oncol, Edinburgh, Midlothian, Scotland
[16] UCL, Dept Med Phys & Biomech Engn, London, England
[17] Univ Coll London Hosp NHS Fdn Trust, Dept Clin Oncol, London, England
[18] Velindre Canc Ctr, Dept Clin Oncol, Cardiff, Wales
[19] Univ Leeds, Leeds Inst Med Res & St Jamess, Leeds, W Yorkshire, England
关键词
Constraints; normal tissue; OAR; SABR; SBRT; stereotactic radiotherapy; BODY RADIATION-THERAPY; TOTAL MESORECTAL EXCISION; RECTAL-CANCER; RISK; ORGAN; RADIOSURGERY; FRACTION; TUMORS; SABR; HYPOFRACTIONATION;
D O I
10.1016/j.clon.2022.02.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past decade, in part as the result of several UK clinical trials and a recent NHS England Commissioning through Evaluation programme. A UK SABR Consortium consensus for normal tissue constraints for SABR was published in 2017, based on the existing literature at the time. The published literature regarding SABR has increased in volume over the past 5 years and multiple UK centres are currently working to develop new SABR services. A review and update of the previous consensus is therefore appropriate and timely. It is hoped that this document will provide a useful resource to facilitate safe and consistent SABR practice. (C) 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:288 / 300
页数:13
相关论文
共 57 条
[1]   LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective [J].
Adebahr, S. ;
Collette, S. ;
Shash, E. ;
Lambrecht, M. ;
Le Pechoux, C. ;
Faivre-Finn, C. ;
De Ruysscher, D. ;
Peulen, H. ;
Belderbos, J. ;
Dziadziuszko, R. ;
Fink, C. ;
Guckenberger, M. ;
Hurkmans, C. ;
Nestle, U. .
BRITISH JOURNAL OF RADIOLOGY, 2015, 88 (1051)
[2]  
[Anonymous], 2019, CONV CAR VERS RAD ST
[3]  
[Anonymous], 2021, ABC07 CANC RES UK
[4]  
[Anonymous], 2018, STEREOTACTIC BODY RA
[5]   Stereotactic body radiation therapy: The report of AAPM Task Group 101 [J].
Benedict, Stanley H. ;
Yenice, Kamil M. ;
Followill, David ;
Galvin, James M. ;
Hinson, William ;
Kavanagh, Brian ;
Keall, Paul ;
Lovelock, Michael ;
Meeks, Sanford ;
Papiez, Lech ;
Purdie, Thomas ;
Sadagopan, Ramaswamy ;
Schell, Michael C. ;
Salter, Bill ;
Schlesinger, David J. ;
Shiu, Almon S. ;
Solberg, Timothy ;
Song, Danny Y. ;
Stieber, Volker ;
Timmerman, Robert ;
Tome, Wolfgang A. ;
Verellen, Dirk ;
Wang, Lu ;
Yin, Fang-Fang .
MEDICAL PHYSICS, 2010, 37 (08) :4078-4101
[6]   Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial [J].
Brand, Douglas H. ;
Tree, Alison C. ;
Ostler, Peter ;
van der Voet, Hans ;
Loblaw, Andrew ;
Chu, William ;
Ford, Daniel ;
Tolan, Shaun ;
Jain, Suneil ;
Martin, Alexander ;
Staffurth, John ;
Camilleri, Philip ;
Kancherla, Kiran ;
Frew, John ;
Chan, Andrew ;
Dayes, Ian S. ;
Henderson, Daniel ;
Brown, Stephanie ;
Cruickshank, Clare ;
Burnett, Stephanie ;
Duffton, Aileen ;
Griffin, Clare ;
Hinder, Victoria ;
Morrison, Kirsty ;
Naismith, Olivia ;
Hall, Emma ;
van As, Nicholas .
LANCET ONCOLOGY, 2019, 20 (11) :1531-1543
[7]  
Chalkidou A, 2021, LANCET ONCOL, V22, P98, DOI 10.1016/S1470-2045(20)30537-4
[8]   Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials [J].
Chang, Joe Y. ;
Senan, Suresh ;
Paul, Marinus A. ;
Mehran, Reza J. ;
Louie, Alexander V. ;
Balter, Peter ;
Groen, Harry J. M. ;
McRae, Stephen E. ;
Widder, Joachim ;
Feng, Lei ;
van den Borne, Ben E. E. M. ;
Munsell, Mark F. ;
Hurkmans, Coen ;
Berry, Donald A. ;
van Werkhoven, Erik ;
Kresl, John J. ;
Dingemans, Anne-Marie ;
Dawood, Omar ;
Haasbeek, Cornelis J. A. ;
Carpenter, Larry S. ;
De Jaeger, Katrien ;
Komaki, Ritsuko ;
Slotman, Ben J. ;
Smit, Egbert F. ;
Roth, Jack A. .
LANCET ONCOLOGY, 2015, 16 (06) :630-637
[9]  
clinicaltrials, SABRCOMET3
[10]   Dose escalation for locally advanced pancreatic cancer: How high can we go? [J].
Colbert, Lauren E. ;
Rebueno, Neal ;
Moningi, Shalini ;
Beddar, Sam ;
Sawakuchi, Gabriel O. ;
Herman, Joseph M. ;
Koong, Albert C. ;
Das, Prajnan ;
Holliday, Emma B. ;
Koay, Eugene J. ;
Taniguchi, Cullen M. .
ADVANCES IN RADIATION ONCOLOGY, 2018, 3 (04) :693-700